NCT07821697Not yet recruitingEarly phase 1
Translational Recording and Characterization of Epilepsy Signals Using Subgaleal EEG During Standard-of-care SEEG Monitoring
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
TRACE is a record-only study evaluating subgaleal EEG (sgEEG) recorded concurrently with standard-of-care stereoelectroencephalography (SEEG) in adults with drug-resistant epilepsy undergoing inpatient epilepsy monitoring. The study will assess the ability of sgEEG to detect seizures and characterize seizure timing, signal quality and stability, and lateralization compared with SEEG.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 10 Sept 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 15 Oct 2027
- Lead sponsor
- Adraxe Corp.
- Diseases
- Epilepsy
- NCT number
- NCT07821697
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 15
- From 15 Oct 2026 to the primary completion date, 15 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any medical, neurological, psychiatric, or social condition that, in the investigator's judgment, would make participation unsafe or interfere with study procedures or data interpretation.
- Active infection, skin condition, or other finding at the planned subgaleal electrode placement site that could increase procedural risk.
- Known bleeding disorder, clinically significant coagulopathy, or use of anticoagulant/antiplatelet therapy that cannot be managed per institutional requirements for the planned procedure.
Other
- Pregnancy or breastfeeding.
- Participation in another investigational study that, in the investigator's judgment, could interfere with TRACE procedures or outcomes.
Who the study is looking for
- Adults aged 18 years or older.
- Diagnosis of drug-resistant epilepsy.
- Scheduled to undergo clinically indicated inpatient standard-of-care stereoelectroencephalography (SEEG) monitoring.
- Able and willing to provide written informed consent.
- In the investigator's judgment, able to comply with study procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnisota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.